Nearly 50 percent of colorectal cancer survivors have continued pain interference
the ONA take:
According to a recent study published in the journal Pain Medicine, researchers from the University of Alabama at Birmingham have found that almost half of colorectal cancer survivors with pain interference during the initial phase of care have continued pain interference after treatment.
For the study, researchers analyzed survey results from participants with colorectal cancer of the Cancer Care Outcomes Research and Surveillance Consortium during the initial phase of care and follow-up.
They identified 2,961 patients during the initial phase and 2,303 patients during follow-up. Results showed that at baseline, 24.7% of participants reported moderate and high pain interference compared with 23.7% during follow-up.
For 46% of participants with baseline pain interference, pain interference was either the same or worse at follow-up.
Researchers found that chemotherapy, comorbidities, depression, female gender, and radiation were associated with moderate and high pain interference at the time of diagnosis and during follow-up. On the other hand, older age was associated with improved pain interference.
The study also showed that those pulmonary disease or heart failure comorbidities had equivalent or increasing pain interference at follow-up.
Almost half of colorectal cancer survivors with pain interference during the initial phase of care have continued pain.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|